cancer testing;Cancer Diagnosis;Exosome;Exosome research;exosomes and microvesicles;Extracellular;extracellular vesicles (EVs)

Foundation Venture Capital Group Commits $1 Million to Hackensack Meridian Health’s First Spin-out Company, EValuate Diagnostics

[ad_1] Newswise — February 8, 2024, Edison, NJ – EValuate Diagnostics, the first spin-out company from the Hackensack Meridian Health…